Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

TransMemBios (AKA: Transmembrane Biosciences)
Profile last edited on: 9/20/2017      CAGE: 1VRY2      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2002
Latest Award
2013
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2585 Nina Street
Pasadena, CA 91107
   (626) 765-6906
   hiephoa@its.caltech.edu
   N/A
Location: Single
Congr. District: 27
County: Los Angeles

Public Profile

Also doing business as Transmembrane Biosciences, the firm is involved with the economical production of membrane proteins in addition to research in membrane proteins of eukaryotes and prokaryotes. The firm also researches defense mechanisms against nerve gas agents and biological/chemical weapons. Currently, the firm is involved with diagnostic technologies for tuberculosis infections and Q fever.

Extent of SBIR involvement

User Avatar
Phase I Awards
10
Phase II Awards
3
Conversion Rate
30.00%
Phase I Dollars
$1,043,000
Phase II Dollars
$2,035,998
Total Awarded
$3,078,998

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2013 2 DHA $900,000
Project Title: Development of an Alternative Screening Method for Detecting Evidence of Mycobacterium Tuberculosis Infections
2009 2 Army $824,998
Project Title: A Point-of-Care Assay for the Detection of Q fever
2009 1 Army $70,000
Project Title: Development of a Point-of-care Assay for the Detection of Crimean-Congo Haemorrhagic Fever (CCHF) Virus, a Militarily Important Pathogen of the CENTCO
2009 2 NSF $706,000
Project Title: Development of a Eukaryotic Membrane Protein Overexpression System
2008 1 USDA $80,000
Project Title: Development of Highly Effective Vaccine to Prevent Fish Tuberculosis for Aquaculture

Key People / Management

  Hiep-Hoa T Nguyen -- President

Company News

There are no news available.